Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6

Research output: Contribution to journal › Article › peer-review

Cite this

@article{ad3aeaabda6142899095b3be2bce12c3,

title = "Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6",

author = "M. Quinn and McMullin, \{Mary Frances\} and F. Lopez and Alexander Thompson and T.R. Lappin",

year = "2003",

month = jul,

language = "English",

volume = "31",

pages = "151--151",

journal = "Experimental Hematology",

issn = "1873-2399",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6

AU - Quinn, M.

AU - McMullin, Mary Frances

AU - Lopez, F.

AU - Thompson, Alexander

AU - Lappin, T.R.

PY - 2003/7

Y1 - 2003/7

M3 - Article

SN - 1873-2399

VL - 31

SP - 151

EP - 151

JO - Experimental Hematology

JF - Experimental Hematology

ER -